...
首页> 外文期刊>BMC Cancer >Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals
【24h】

Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals

机译:斯里兰卡乳腺癌患者和高危人群BRCA1基因的新序列变异和高频率的反复多态性

获取原文
           

摘要

Background Breast Cancer is the most commonly diagnosed cancer among Sri Lankan women. Germline mutations in the susceptibility genes BRCA1 and BRCA2 in hereditary breast/ovarian cancer, though low in prevalence, are highly penetrant and show geographical variations. There have been only a few reports from Asia on mutations in BRCA1/2 genes and none from Sri Lanka. Methods A total of 130 patients with (N = 66) and without (N = 64) a family history of breast cancer, 70 unaffected individuals with a family history of breast cancer and 40 control subjects were analysed for BRCA1 mutations. All but exon 11 were screened by single strand conformation analysis (SSCP) and heteroduplex analysis. PCR products which showed abnormal patterns in SSCP were sequenced. Exon 11 was directly sequenced. Results Nineteen sequence variants were found in BRCA1 gene. Two novel deleterious frame-shift mutations; c.3086delT/exon11 (in one patient) and c.5404delG/exon21 (in one patient and two of her family members) were identified. A possibly pathogenic novel missense mutation (c.856T>G/exon 11) and three novel intronic variants (IVS7+36C>T, IVS7+41C>T, IVS7+49del15) were characterised. Ten previously reported common polymorphisms and three previously reported intronic variants were also observed. Conclusion After screening of 66 patients with family history and 64 sporadic breast cancer patients, 2 deleterious mutations (c.3086delT and c.5404delG) in two families were identified and two more possibly pathogenic mutations (c.856T>G and IVS17-2A>T) in two families were identified. Data base BRCA1 - Gene Bank: Accession # U14680 Version # 14680.1
机译:背景技术乳腺癌是斯里兰卡女性中最常被诊断出的癌症。遗传性乳腺癌/卵巢癌的易感基因BRCA1和BRCA2中的种系突变,尽管患病率低,但具有很高的渗透性并显示出地理差异。亚洲只有很少的关于BRCA1 / 2基因突变的报道,斯里兰卡也没有。方法分析130例有乳腺癌家族史的患者(N = 66)和无乳腺癌家族史(N = 64),70名未患乳腺癌家族史的患者和40例对照受试者的BRCA1突变。通过单链构象分析(SSCP)和异源双链分析筛选除外显子11外的所有蛋白。对在SSCP中显示异常模式的PCR产物进行测序。外显子11被直接测序。结果在BRCA1基因中发现了19个序列变异。两个新颖的有害移码突变;确定了c.3086delT / exon11(一名患者)和c.5404delG / exon21(一名患者及其两个家庭成员)。表征了可能的致病性新错义突变(c.856T> G / exon 11)和三个新的内含子变体(IVS7 + 36C> T,IVS7 + 41C> T,IVS7 + 49del15)。还观察到十个先前报道的常见多态性和三个先前报道的内含子变体。结论在对66例具有家族史的患者和64例散发性乳腺癌患者进行筛查后,鉴定出两个家族中的2个有害突变(c.3086delT和c.5404delG),以及两个可能的致病突变(c.856T> G和IVS17-2A>)。 T)在两个家庭中被确定。数据库BRCA1-基因库:登录号U14680版本号14680.1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号